Evaluation of An I226R and A137R deletion mutant from a genotype I/II recombinant African swine fever virus strain as a live attenuated vaccine in pigs
Abstract
The emergence of highly lethal genotype I/II recombinant African swine fever virus (ASFV) strains in China has rendered existing genotype II-based live attenuated vaccines ineffective, underscoring the urgent need for novel vaccine candidates. Although single-gene deletions of A137R or I226R have shown promise against genotype II strains, their efficacy and safety in the context of recombinant strains remain unexplored. Using homologous recombination, we constructed a single gene-deleted mutant (JX23-02ΔI226R) and a double gene-deleted mutant (JX23-02ΔI226RΔA137R) from the genotype I/II recombinant ASFV strain JX23-02. The replication kinetics, pathogenicity, immunogenicity, and protective efficacy of these mutants were evaluated in vitro and in pigs. Both deletion mutants exhibited significantly reduced replication in porcine alveolar macrophages. Immunization with JX23-02ΔI226R resulted in 40% survival, and surviving pigs were protected against lethal challenge. In contrast, JX23-02ΔI226RΔA137R was fully attenuated: all immunized pigs survived challenge without any clinical signs (maximum rectal temperature 40.2 °C) and developed detectable p54-specific antibody responses. Moreover, viral shedding and tissue viral loads were markedly lower in the double-deletion group than in the single-deletion group. The double gene-deleted mutant JX23-02ΔI226RΔA137R represents a promising live attenuated vaccine candidate against genotype I/II recombinant ASFV strains, supporting the use of multigene deletion strategies for ASF vaccine development.
Related
- A Highly Permissive K-C4 Cell Clone for Genotype II African Swine Fever Virus Reveals Passage-Dependent Hemadsorption Changes Associated with EP402R Deletion.
- A pentaplex qPCR for the simultaneous detection and differentiation of genotype I, II, I/II recombinant, and fluorescence-tagged African swine fever viruses
- Deletion of pyrE disrupts pyrimidine de novo synthesis, attenuates virulence, and confers protective immunity as a live attenuated vaccine candidate against Brucella melitensis
- A dual recombinant strategy to quantify PreS1 antibody in hepatitis B patients with genotype B or C virus by ELISA
- Genotype x environment interaction for stomata traits in a rice recombinant inbred population
BibTeX
@article{zhang2026evaluation,
title = {{Evaluation of An I226R and A137R deletion mutant from a genotype I/II recombinant African swine fever virus strain as a live attenuated vaccine in pigs}},
author = {Han Zhang and Qixuan Li and Nannan Li and Ying Wang and Tianying Hou and Hongliang Wang and Rongliang Hu and Yanyan Zhang and Shoufeng Zhang and Faming Miao},
journal = {Veterinary Research},
year = {2026},
month = aug,
doi = {10.1186/s13567-026-01827-6},
url = {https://hal.science/hal-05731890v1},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Evaluation of An I226R and A137R deletion mutant from a genotype I/II recombinant African swine fever virus strain as a live attenuated vaccine in pigs
AU - Han Zhang
AU - Qixuan Li
AU - Nannan Li
AU - Ying Wang
AU - Tianying Hou
AU - Hongliang Wang
AU - Rongliang Hu
AU - Yanyan Zhang
AU - Shoufeng Zhang
AU - Faming Miao
PY - 2026
DA - 2026/08/31
JO - Veterinary Research
DO - 10.1186/s13567-026-01827-6
UR - https://hal.science/hal-05731890v1
AB - The emergence of highly lethal genotype I/II recombinant African swine fever virus (ASFV) strains in China has rendered existing genotype II-based live attenuated vaccines ineffective, underscoring the urgent need for novel vaccine candidates. Although single-gene deletions of A137R or I226R have shown promise against genotype II strains, their efficacy and safety in the context of recombinant strains remain unexplored. Using homologous recombination, we constructed a single gene-deleted mutant (JX23-02ΔI226R) and a double gene-deleted mutant (JX23-02ΔI226RΔA137R) from the genotype I/II recombinant ASFV strain JX23-02. The replication kinetics, pathogenicity, immunogenicity, and protective efficacy of these mutants were evaluated in vitro and in pigs. Both deletion mutants exhibited significantly reduced replication in porcine alveolar macrophages. Immunization with JX23-02ΔI226R resulted in 40% survival, and surviving pigs were protected against lethal challenge. In contrast, JX23-02ΔI226RΔA137R was fully attenuated: all immunized pigs survived challenge without any clinical signs (maximum rectal temperature 40.2 °C) and developed detectable p54-specific antibody responses. Moreover, viral shedding and tissue viral loads were markedly lower in the double-deletion group than in the single-deletion group. The double gene-deleted mutant JX23-02ΔI226RΔA137R represents a promising live attenuated vaccine candidate against genotype I/II recombinant ASFV strains, supporting the use of multigene deletion strategies for ASF vaccine development.
SN - 0928-4249
SN - 1297-9716
ER -